First, the upregulation of immune checkpoint molecules such as programmed cell death ligand 1 (PD-L1) on tumor cells interacts with programmed cell death protein 1 (PD-1) on T cells, suppressing glucose uptake and glycolysis in T cells, thereby diminishing their effector functions (101). Here, PDCD1 is linked to neoplasm.